Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
Status:
Completed
Trial end date:
2018-08-30
Target enrollment:
Participant gender:
Summary
This is a randomized, multi-center, parallel-group Phase I study to evaluate the
pharmacodynamics (PD) of Medroxyprogesterone Acetate (MPA) after a single subcutaneous (SC)
injection of 150 mg/mL or 300 mg/2 mL Depo-Provera CI in the abdomen of women of reproductive
age with a confirmed ovulatory baseline cycle.
Phase:
Phase 1
Details
Lead Sponsor:
FHI 360
Collaborators:
Asociación Dominicana Pro Bienestar de la Familia, Inc. Oregon Health and Science University